Melpomeni Styliadou
Vice President, Global Program Leader, Health Data Partnerships Takeda Pharmaceutical
Meni is leading a Takeda Global Program to build sustainable health data partnerships to unleash the power of data and digital in the benefit of patients, science and society. Meni is also the Founder and Project Leader of the H2O, a public private partnership among 23 organisations funded through the Innovative Medicines Initiative (IMI). The goal of the H2O is το equip patients with digital tools to monitor their outcomes in a standardised manner while being in control of their data.
Meni joined Takeda on the 1st of October 2015 as VP Public Policy and Government Affairs for Europe & Canada (EUCAN). Prior to joining Takeda, Meni worked for 9 years for Novartis in several roles in public policy and ethical leadership and prior to that, Meni has held a number of senior positions in both the public and private sectors focusing on how to accelerate broadband in Europe.
Meni started her career in the European Commission as a legal expert focusing on telecom law and policy. She studied law in Greece and Belgium, and she specialised in anti-trust law.
Seminars
- Share early learnings from developing a syndicated registry model, including how greater collaboration and transparency could strengthen confidence in RWE and support its acceptance for regulatory and HTA decision-making
- Examine how sharing data infrastructure, costs and research efforts across pharmaceutical companies and healthcare organisations can reduce the time, complexity and cost of generating high-quality RWE
- Discuss the practical challenges of establishing these collaborative models, including aligning multiple stakeholders, determining fair market value for data and creating sustainable partnership frameworks
